Bayview Legacy, LLC 4

What Happened

• Bayview Legacy, LLC (a reported 10% owner of Arteris, Inc.) sold a total of 40,000 Arteris shares in two open‑market transactions: 7,012 shares on 2026‑03‑25 at a weighted average price of $18.03 (proceeds $126,433) and 32,988 shares on 2026‑03‑26 at a weighted average price of $18.35 (proceeds $605,191). Total proceeds were about $731,624. These were sales (not purchases), which are often routine dispositions rather than a direct signal of company prospects.

Key Details

• Transaction dates: 2026‑03‑25 (7,012 shares @ $18.03) and 2026‑03‑26 (32,988 shares @ $18.35).
• Total shares sold: 40,000; total reported proceeds: ~$731,624.
• Filing date: Form 4 filed 2026‑03‑27 for report period beginning 2026‑03‑25 — appears timely (reported within two business days).
• Shares owned after the transactions: Not specified in the summary data provided on this filing.
• Footnotes of note:
  • F1: Sales were made pursuant to a 10b5‑1 trading plan adopted March 5, 2025 (prearranged sales).
  • F3/F5: Reported prices are weighted averages; shares were sold in multiple trades at prices within stated ranges (3/25 sale: $18.00–$18.08; 3/26 sale: $18.00–$18.70). The filer can supply per‑trade price details on request.
  • F2/F4: K. Charles Janac is the manager of Bayview Legacy, LLC, is deemed to control the LLC’s voting/dispositive power, and has separately filed a Form 4 reporting the same transactions based on that control.

Context

• Because these sales were executed under a previously adopted 10b5‑1 plan, they were likely prearranged and automated, which is common for controlled investors and does not necessarily reflect new information about the company. As a 10% owner (an institutional/large holder), Bayview Legacy is not an operating executive; filings note the manager (K. Charles Janac) filed separately to reflect his control.